Skip to main content
DYAI
NASDAQ Life Sciences

Dyadic International Amends 10-K, Reveals Favorable Convertible Note Terms for Insiders

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.785
Mkt Cap
$28.586M
52W Low
$0.655
52W High
$1.346
52W Position info
20% above low
Off High info
42% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

DYAI sits 20% above its 52-week low of $0.655 on light trading volume (0.1× avg).

Summary

Dyadic International filed an amended 10-K to include omitted Part III details, revealing a reduced conversion price for $5.09 million in related-party convertible notes, favoring insiders and increasing potential dilution.


Key Events · Financing and Capital Events · DYAI

  • Related-Party Convertible Note Terms Finalized

    The filing details the $6.0 million 8.0% Senior Secured Convertible Promissory Notes, with $5.09 million principal outstanding as of April 24, 2026. These notes are held by related parties, including the CEO's family trusts.

  • Conversion Price Reduced for Insiders

    On December 23, 2025, the conversion price for these related-party notes was significantly reduced to $1.05 per share from previously higher prices ($1.79 and $1.40), making conversion more favorable for the noteholders.

  • Significant Insider Ownership and Potential Dilution

    CEO Mark A. Emalfarb holds 17.7% beneficial ownership, and all executive officers and directors as a group hold 20.9% beneficial ownership, including shares from exercisable options and convertible notes. The favorable conversion terms for the outstanding notes could lead to further dilution.

  • Omitted Part III Information Included

    This amendment provides standard disclosures on directors, executive compensation, security ownership, and related person transactions, which were previously omitted from the original 10-K filed on March 25, 2026.


Analysis · DYAI · Life Sciences

This 10-K/A filing provides the previously omitted Part III information from the company's annual report. The most significant disclosure is the amendment to the $6.0 million Senior Secured Convertible Promissory Notes, particularly the reduction of the conversion price to $1.05 per share on December 23, 2025. This change, benefiting related parties including the CEO's family trusts, makes it significantly easier for them to convert debt into equity at a lower price, increasing potential dilution for existing shareholders. Given the company's small market capitalization, these related-party financing terms represent a material aspect of its capital structure and future dilution risk.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DYAI was trading at $0.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.6M. The 52-week trading range was $0.65 to $1.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DYAI - Latest Insights

DYAI
Nov 13, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.327
Real-time Price: $0.32415 info
Change: -$0.00285 (-0.87%) info
Market Cap: $12.996M info
DYAI
Nov 12, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.3501
Real-time Price: $0.32415 info
Change: -$0.02595 (-7%) info
Market Cap: $12.996M info
DYAI
Sep 25, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4198
Real-time Price: $0.32415 info
Change: -$0.09565 (-23%) info
Market Cap: $12.996M info
DYAI
Aug 17, 2026, 7:27 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.710
Real-time Price: $0.32415 info
Change: -$0.38585 (-54%) info
Market Cap: $12.996M info
DYAI
Aug 14, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7702
Real-time Price: $0.32415 info
Change: -$0.44605 (-58%) info
Market Cap: $12.996M info